Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Palliative Prostate Artery Embolization for Prostate Cancer: A Case Series

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Commentary on Drug-Eluting Technologies

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Outcome Measures After Sclerotherapy of Venous Malformations: A Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Mechanical thrombectomy in basilar artery thrombosis: technical advances and safety in a 10-year experience

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Simulation: moving from technology challenge to human factors success

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. NORDSTAR - Paving the way for a new era in asthma research

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictive value of AZGP1 following radical prostatectomy for prostate cancer: a cohort study and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pressure Difference Estimation in Carotid Bulbs using Vector Flow Imaging - A Phantom Study

    Research output: Contribution to journalConference articleResearchpeer-review

View graph of relations

INTRODUCTION: Prostate artery embolization (PAE) is recognized as a treatment for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia. LUTS and urinary retention are common in men with prostate cancer (PCa). The purpose of this study was to estimate the efficacy and safety of palliative PAE on LUTS or urinary retention in men with advanced PCa.

MATERIALS AND METHODS: This prospective, single-center trial was conducted from March 2017 to November 2018. The trial protocol was registered online ( Identifier: NCT03104907). Only men with advanced PCa suffering from LUTS or urinary retention were included. The primary outcome was the ability to void without a catheter and International Prostate Symptom Score (IPSS) in non-catheter-dependent patients. The paired t test was used to analyze changes from baseline with 95% confidence intervals (CI). A p value < 0.05 was considered statistically significant.

RESULTS: Seventeen patients were assessed for eligibility, and 15 patients with a mean age of 73.8 years were enrolled. Four men did not complete follow-up: cancer-related death (n = 2), lost to follow-up (n = 1), and unsuccessful embolization due to severe atherosclerosis (n = 1). Bilateral embolization was achieved in ten cases, and urinary retention resolved in one of six patients. LUTS improved in the remaining (n = 5) patients by a mean 12.2-point reduction in IPSS (95% CI - 23.53; - 0.87). According to the CIRSE classification, two grade 1 and two grade 3 complications occurred.

CONCLUSION: In this study, palliative PAE was safe and efficient for treatment for LUTS associated with PCa.

LEVEL OF EVIDENCE: Level 4, Case Series. Trial registration Identifier: NCT03104907.

Original languageEnglish
JournalCardiovascular and Interventional Radiology
Issue number10
Pages (from-to)1405-1412
Number of pages8
Publication statusPublished - 15 Oct 2019

    Research areas

  • Clinical trial, Embolization, Lower urinary tract symptoms, Palliative care, Prostatic neoplasms, Therapeutic, Urinary retention

ID: 58147785